10X Genomics Correlations
| TXG Stock | USD 13.41 0.05 0.37% |
The current 90-days correlation between 10X Genomics and Twist Bioscience Corp is 0.41 (i.e., Very weak diversification). The correlation of 10X Genomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
10X Genomics Correlation With Market
Weak diversification
The correlation between 10X Genomics and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding 10X Genomics and DJI in the same portfolio, assuming nothing else is changed.
Moving together with 10X Stock
| 0.72 | CVM | CEL SCI Corp Downward Rally | PairCorr |
| 0.8 | DNA | Ginkgo Bioworks Holdings | PairCorr |
| 0.77 | IQV | IQVIA Holdings Sell-off Trend | PairCorr |
| 0.72 | VOR | Vor Biopharma | PairCorr |
| 0.65 | LIXTW | Lixte Biotechnology | PairCorr |
Moving against 10X Stock
| 0.64 | ERNA | Eterna Therapeutics | PairCorr |
| 0.64 | EXAS | EXACT Sciences | PairCorr |
| 0.59 | INO | Inovio Pharmaceuticals | PairCorr |
| 0.48 | KTTAW | Pasithea Therapeutics | PairCorr |
| 0.45 | FLGC | Flora Growth Corp | PairCorr |
| 0.67 | GERN | Geron Aggressive Push | PairCorr |
| 0.56 | IBIO | iBio, Common Stock | PairCorr |
| 0.46 | HUMA | Humacyte | PairCorr |
| 0.43 | GNFT | Genfit SA | PairCorr |
| 0.71 | RVPHW | Reviva Pharmaceuticals | PairCorr |
| 0.46 | ITRM | Iterum Therapeutics PLC | PairCorr |
Related Correlations Analysis
| 0.16 | 0.56 | -0.37 | 0.09 | TWST | ||
| 0.16 | -0.05 | 0.02 | -0.17 | FATE | ||
| 0.56 | -0.05 | -0.54 | -0.02 | BEAM | ||
| -0.37 | 0.02 | -0.54 | 0.41 | VCYT | ||
| 0.09 | -0.17 | -0.02 | 0.41 | GH | ||
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between 10X Stock performing well and 10X Genomics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze 10X Genomics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TWST | 2.81 | (0.20) | 0.00 | (0.05) | 0.00 | 5.79 | 16.34 | |||
| FATE | 4.59 | 0.07 | 0.05 | 0.10 | 4.71 | 10.09 | 29.40 | |||
| BEAM | 2.66 | (0.22) | 0.00 | (0.01) | 0.00 | 5.71 | 20.92 | |||
| VCYT | 2.10 | (0.04) | 0.00 | 0.06 | 2.41 | 2.98 | 17.56 | |||
| GH | 2.42 | 0.51 | 0.18 | 0.49 | 2.33 | 6.69 | 18.08 |
10X Genomics Corporate Management
| James Wilbur | Chief Officer | Profile | |
| Mennah Moustafa | Chief Officer | Profile | |
| Ruth Backer | Chief Officer | Profile | |
| Florian Baumgartner | Senior Manager | Profile | |
| Jonathan Schimmel | VP Operations | Profile | |
| Jim Goodrich | Chief Operations | Profile |